Strong demand for new radiation therapy and x-ray imaging products boosted fiscal year 2004 to record earnings, revenues, net orders, and a strong year-ending backlog for Varian Medical Systems. The company, which reported flat orders in Q3 for oncology equipment from North American customers, raised its guidance for fiscal 2005, predicting an increase of 13% to 14% and a rise in earnings of nearly 20% over 2004.
Strong demand for new radiation therapy and x-ray imaging products boosted fiscal year 2004 to record earnings, revenues, net orders, and a strong year-ending backlog for Varian Medical Systems. The company, which reported flat orders in Q3 for oncology equipment from North American customers, raised its guidance for fiscal 2005, predicting an increase of 13% to 14% and a rise in earnings of nearly 20% over 2004.
Net earnings grew about 18% in the fourth quarter ended Sept. 30, to $52 million compared with $44 million in the previous year's fourth quarter. Net earnings for fiscal year 2004 were up 28% to $167 million versus net earnings of $131 million for fiscal year 2003. Fourth-quarter revenues were $345 million, up 14% from the year-ago quarter, bringing revenues for the fiscal year to $1.2 billion, 19% higher than total revenues for fiscal year 2003. Net orders were $412 million for the fourth quarter, up 28% from the year-ago quarter. Total net orders for fiscal year 2004 were $1.4 billion, up 21% from the fiscal year 2003 total. The backlog at year's end was $970 million, 20% higher than at the end of fiscal year 2003.
Oncology Systems revenues for the fiscal year were $1 billion, up 20% from fiscal year 2003. Net orders for the quarter accounted for $351 million, up 24% from the same period last year, and $1.2 billion for the fiscal year, up 20% from fy 2003 totals. Net orders for the year were up 10% in North America and 37% in international markets.
Revenues for the X-Ray Products business, including tubes and amorphous silicon flat-panel digital imagers, were $45 million in the fourth quarter, up 21% from the year-ago quarter. For fy 2004, X-Ray revenues were a record $165 million, up 8% from fiscal year 2003.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
GE HealthCare Launches AI Mammography Platform with Key Applications from iCAD
November 30th 2023Offering an all-in-one platform of artificial intelligence (AI) applications, MyBreastAI Suite reportedly facilitates early breast cancer detection and enhances efficiency with breast imaging workflows.